Published: 3 August 2016
Publications
Information on the scheduling of cannabidiol and tetrahydrocannabinol as prescription medicines
Medsafe has published the OIA requesting information on the scheduling of cannabidiol and tetrahydrocannabinol as prescription medicines. Medsafe has also published the clinical evaluation reports regarding this product.
- Letter to requestor (pdf 242KB, 6 pages)
- Excerpt of 85th meeting minutes of MAAC (pdf 192KB, 4 pages)
- Excerpt of 86th meeting minutes of MAAC (pdf 161KB, 4 pages)
- Excerpt of 89th meeting minutes of MAAC (pdf 16KB, 1 page)
- Excerpt of 90th meeting minutes of MAAC (pdf 239KB, 6 pages)
- Memo to DDG - Savitex referral to MAAC (pdf 53KB, 2 pages)
- Letter to applicant - Savitex referral to MAAC (pdf 28KB, 1 page)
- Memo to MAAC secretary 1 - Savitex evaluation post-MAAC and additional information (pdf 43KB, 1 page)
- Quality review – FINAL (pdf 45KB, 1 page)
- MAAC Clinical evaluation 1 (pdf 136KB, 4 pages)
- MAAC Clinical evaluation 2 (pdf 251KB, 6 pages)
- MAAC Clinical evaluation 3 (pdf 544KB, 10 pages)
- MAAC Clinical evaluation 4 (pdf 533KB, 10 pages)
- MAAC Clinical evaluation 5 (pdf 275KB, 6 pages)
- MAAC Clinical evaluation 6 (pdf 268KB, 6 pages)
- MAAC Clinical evaluation 7 (pdf 50KB, 1 page)
- Memo to MAAC secretary 2 - Savitex referral to MAAC (pdf 156KB, 4 pages)
- Email - Controlled drugs to go into First Schedule (pdf 45KB, 2 pages)
- Controlled drugs that are to be entered as Pt1 of Schedule 1 of Med Regs (pdf 79KB, 4 pages)
- Email - Medicines Amendment Regulations 2011 - Controlled drugs (pdf 49KB, 2 pages)
- Memo to Minister of Health 1 - Approval to implement changes to Regulations (pdf 61KB, 2 pages)
- Cabinet Social Policy Committee - Approval to implement changes to Regulations (pdf 226KB, 10 pages)
- Consultation on Cabinet and Cabinet Committee submissions (pdf 112KB, 2 pages)
- Memo to Minister of Health 2 - Approval to submit Regulation changes to CLC (pdf 88KB, 2 pages)
- Cabinet Legislation Committee - Changes to Medicines Regulations (pdf 185KB, 6 pages)
- Medicines Amendment Regulations 2011 (pdf 193KB, 6 pages)